Daiichi Sankyo is a global pharmaceutical company striving to contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals. As a local subsidiary of Daiichi Sankyo, Daiichi Sankyo Hong Kong commences the sales promotion as from April 1, 2013, providing all the sales and marketing support and up-to-date, evidence based medical information of Daiichi Sankyo’s pharmaceutical products to the healthcare professionals in Hong Kong and Macau.

​

Daiichi Sankyo Hong Kong (DSHK) is the wholly-owned subsidiary of Daiichi Sankyo Ltd., Japan. Starting April 1, 2013, DSHK commences its own sales operation and is responsible for the marketing and promotion of Daiichi Sankyo products in Hong Kong/Macau in an ethical, trusted and respectful manner.

​

In Hong Kong / Macau, we market a range of high-quality products from antibiotics to antifibrinolytics. Daiichi Sankyo Hong Kong will strive to serve the local medical needs of the community to help fulfill our corporate mission of contributing to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals.